AGOSTINI'S LIMITED AND ITS SUBSIDIARIES

UNAUDITED HALF YEAR CONSOLIDATED RESULTS

Notes

The summary consolidated financial statements are prepared in accordance with the criteria developed by management. Under management's established criteria, management discloses the summary consolidated statements of financial position, income, comprehensive income and changes in equity and cash flow. These summary consolidated financial statements are derived from the unaudited consolidated financial statements of Agostini's Limited and its subsidiaries for the period ended 31 March 2023, and are prepared in accordance with International Financial

  1. Reporting Standards.
  2. Segment Information - Business Segments

Pharmaceutical &

Consumer

Energy, Industrial

Total

Health Care

Brands

and Holdings

$'000

$'000

$'000

$'000

$'000

$'000

$'000

$'000

2023

2022

2023

2022

2023

2022

2023

2022

Revenue

803,662

669,085

1,447,765

1,299,513

149,289

139,292

2,400,716

2,107,890

Operating Profit

117,184

90,545

132,680

119,256

20,394

16,895

270,258

226,696

Profit before tax

106,510

82,482

126,530

113,145

90,794

13,776

323,834

209,403

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Agostini's Ltd. published this content on 12 May 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 May 2023 13:46:03 UTC.